Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 194,905 | 4,762 | 59,640 | 55,570 | 37,365 |
| Marketable Securities | 1,140,445 | 291,370 | 329,462 | 253,374 | 225,459 |
| Receivables | 43,213 | 5,014 | 15,678 | 19,947 | 3,607 |
| Inventories | 11,381 | 10,726 | 11,109 | 11,346 | 12,952 |
| Other current assets | 47,743 | 14,948 | 10,063 | 9,814 | 8,817 |
| TOTAL | $1,437,687 | $326,820 | $425,952 | $350,051 | $288,200 |
| Non-Current Assets | |||||
| PPE Net | 48,851 | 47,463 | 65,601 | 71,336 | 70,368 |
| Investments And Advances | 582,889 | 57,088 | 0 | 0 | 0 |
| Intangibles | 76,501 | 76,501 | 76,501 | 76,501 | 76,501 |
| Other Non-Current Assets | 4,244 | 994 | 817 | 754 | 6,552 |
| TOTAL | $712,485 | $182,046 | $142,919 | $148,591 | $153,421 |
| Total Assets | $2,150,172 | $508,866 | $568,871 | $498,642 | $441,621 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,854 | 4,782 | 2,816 | 2,363 | 2,703 |
| Accrued Expenses | 52,676 | 25,767 | 30,436 | 18,416 | 20,374 |
| Other current liabilities | 493 | 446 | 19,907 | 10,127 | 5,567 |
| TOTAL | $82,002 | $56,163 | $72,222 | $61,246 | $64,047 |
| Non-Current Liabilities | |||||
| Long Term Debt | 246,950 | 245,207 | 243,464 | 241,699 | 125,000 |
| Deferred Revenues | 13,892 | 18,949 | 14,352 | 21,428 | 24,473 |
| Other Non-Current Liabilities | 92,901 | 100,647 | 113,173 | 125,769 | 135,192 |
| TOTAL | $350,595 | $364,875 | $408,524 | $430,967 | $341,242 |
| Total Liabilities | $432,597 | $421,038 | $480,746 | $492,213 | $405,289 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 174,105 | 160,923 | 153,831 | 135,939 | 131,382 |
| Common Shares | 17 | 15 | 15 | 13 | 13 |
| Retained earnings | -1,424,051 | -2,117,941 | -2,021,010 | -1,867,486 | -1,786,309 |
| Other shareholders' equity | -6,316 | -2,111 | -2,363 | -2,170 | -1,567 |
| TOTAL | $1,717,575 | $87,828 | $88,125 | $6,429 | $36,332 |
| Total Liabilities And Equity | $2,150,172 | $508,866 | $568,871 | $498,642 | $441,621 |